Luo J - Search Results

1

The influence of drug-induced metabolic enzyme activity inhibition and CYP3A4 gene polymorphism on aumolertinib metabolism.

Ye F, Ni J, Li X, Wang J, Luo J, Wang S, Xu X, Zhong Y, Qian J, Xiao Z. Ye F, et al. Among authors: luo j. Front Pharmacol. 2024 May 24;15:1392849. doi: 10.3389/fphar.2024.1392849. eCollection 2024. Front Pharmacol. 2024. PMID: 38855755 Free PMC article.

2

Functional evaluation of CYP2C19 and CYP3A4 gene polymorphism on ibuprofen metabolism.

Yuan LJ, Li XY, Ni JH, Wang J, Xu XY, Luo JC, Zhou Q, Hu GX, Cai JP, Qian JC. Yuan LJ, et al. Among authors: luo jc. Toxicol Appl Pharmacol. 2023 Sep 15;475:116653. doi: 10.1016/j.taap.2023.116653. Epub 2023 Aug 14. Toxicol Appl Pharmacol. 2023. PMID: 37574146

3

Gene Polymorphisms and Drug-Drug Interactions Determine the Metabolic Profile of Blonanserin.

Ye F, Li X, Ni J, Xu X, Luo J, Zhong Y, Wang Y, Wang S, Zhang Y, Hu G, Qian J. Ye F, et al. Among authors: luo j. J Pharmacol Exp Ther. 2024 Jan 2;388(1):190-200. doi: 10.1124/jpet.123.001767. J Pharmacol Exp Ther. 2024. PMID: 37863485

4

Cyy-287, a novel pyrimidine-2,4-diamine derivative, efficiently mitigates inflammatory responses, fibrosis, and lipid synthesis in obesity-induced cardiac and hepatic dysfunction.

Ni J, Zhang X, Huang H, Ni Z, Luo J, Zhong Y, Hui M, Liu Z, Qian J, Zhang Q. Ni J, et al. Among authors: luo j. PeerJ. 2024 Feb 29;12:e17009. doi: 10.7717/peerj.17009. eCollection 2024. PeerJ. 2024. PMID: 38436035 Free PMC article.

5

The impact of CYP3A4 genetic polymorphism on crizotinib metabolism and drug-drug interactions.

Wang J, Xu XY, Li XY, Luo JC, Zhang ZY, Chen J, Cai JP, Zhang LK, Qian JC. Wang J, et al. Among authors: luo jc. Toxicol Appl Pharmacol. 2024 Aug;489:117016. doi: 10.1016/j.taap.2024.117016. Epub 2024 Jun 24. Toxicol Appl Pharmacol. 2024. PMID: 38925514

6

Drug-induced enzyme activity inhibition and CYP3A4 genetic polymorphism significantly shape the metabolic characteristics of furmonertinib.

Zhou Q, Ye Z, Xu X, Zhong Y, Luo J, Zhang Z, Chen J, Chen Z, Cai J, Zhang X, Qian J. Zhou Q, et al. Among authors: luo j. Toxicology. 2024 Sep;507:153903. doi: 10.1016/j.tox.2024.153903. Epub 2024 Aug 3. Toxicology. 2024. PMID: 39098371

7

New drug combination regimen based on pharmacokinetic characteristics-Erdafitinib combined with sertraline or duloxetine.

Zhang XD, Xu XY, Zhong YS, Zhang ZY, Jin LH, Luo JC, Ye F, Ni JH, Chen J, Chen GZ, Qian JC, Liu ZG. Zhang XD, et al. Among authors: luo jc. Biomed Pharmacother. 2024 Oct;179:117414. doi: 10.1016/j.biopha.2024.117414. Epub 2024 Sep 10. Biomed Pharmacother. 2024. PMID: 39260324 Free article.

8

Critical considerations for co-administering rivaroxaban and vonoprazan: Unveiling potential pharmacokinetic interactions.

Xu XY, Zhang ZY, Zhang XD, Luo JC, Zhong YS, Jin LH, Dai DP, Qian JC. Xu XY, et al. Chem Biol Interact. 2025 Jan 25;406:111342. doi: 10.1016/j.cbi.2024.111342. Epub 2024 Dec 4. Chem Biol Interact. 2025. PMID: 39643151

9

A Response to: Letter to the Editor Regarding Effects of Manual Acupuncture Versus Sham Acupuncture in patients with Post-Stroke Depression: A Randomized Clinical Trial.

Wei C, Chen J, Liu Y, Luo J. Wei C, et al. Among authors: luo j. Neurol Ther. 2025 Jan 24. doi: 10.1007/s40120-024-00702-w. Online ahead of print. Neurol Ther. 2025. PMID: 39853553 No abstract available.

10

The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences.

Zhao S, Luo J, Guo W, Li L, Pu S, Dong L, Zhu W, Gao R. Zhao S, et al. Among authors: luo j. Vaccines (Basel). 2025 Jan 17;13(1):81. doi: 10.3390/vaccines13010081. Vaccines (Basel). 2025. PMID: 39852860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,362 results

Search Page

Filters